Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | dual specificity protein kinase clk2 | 0.006 | 0.002 | 0.0107 |
Brugia malayi | Serine/threonine-protein kinase Pim-3 | 0.0155 | 0.1101 | 0.5818 |
Echinococcus multilocularis | proto oncogene serine:threonine protein kinase | 0.0155 | 0.1101 | 0.5863 |
Echinococcus granulosus | proto oncogene serine:threonine protein kinase | 0.0155 | 0.1101 | 0.5863 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0138 | 0.0908 | 0.4837 |
Trichomonas vaginalis | CMGC family protein kinase | 0.006 | 0.002 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0163 | 0.1187 | 0.6286 |
Leishmania major | protein kinase, putative | 0.006 | 0.002 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0942 | 1 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0224 | 0.1877 | 1 |
Trypanosoma cruzi | kinetoplastid kinetochore protein 19, putative | 0.006 | 0.002 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0138 | 0.0908 | 0.4837 |
Giardia lamblia | Kinase, CMGC CLK | 0.006 | 0.002 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0942 | 1 | 0.5 |
Loa Loa (eye worm) | CMGC/CLK protein kinase | 0.006 | 0.002 | 0.0107 |
Echinococcus multilocularis | c Jun NH2 terminal kinase | 0.0224 | 0.1877 | 1 |
Onchocerca volvulus | Serine\/threonine protein kinase homolog | 0.0155 | 0.1101 | 0.5 |
Brugia malayi | Stress-activated protein kinase jnk-1 | 0.0224 | 0.1877 | 1 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.0942 | 1 | 0.5 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.0155 | 0.1101 | 0.5863 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.0942 | 1 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0122 | 0.0728 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0138 | 0.0908 | 0.4781 |
Toxoplasma gondii | cell-cycle-associated protein kinase CLK, putative | 0.006 | 0.002 | 0.5 |
Trypanosoma cruzi | kinetoplastid kinetochore protein 19, putative | 0.006 | 0.002 | 0.5 |
Echinococcus granulosus | c-Jun N-terminal kinases | 0.0224 | 0.1877 | 1 |
Trypanosoma cruzi | kinetoplastid kinetochore protein 10, putative | 0.006 | 0.002 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0155 | 0.1101 | 0.5818 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0122 | 0.0728 | 0.5 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.0942 | 1 | 0.5 |
Echinococcus granulosus | dual specificity protein kinase clk2 | 0.006 | 0.002 | 0.0107 |
Trypanosoma cruzi | kinetoplastid kinetochore protein 10, putative | 0.006 | 0.002 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0122 | 0.0728 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0163 | 0.1187 | 0.6286 |
Trypanosoma brucei | kinetoplastid kinetochore protein 19 | 0.006 | 0.002 | 0.5 |
Trypanosoma brucei | kinetoplastid kinetochore protein 10 | 0.006 | 0.002 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0155 | 0.1101 | 0.5818 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0122 | 0.0728 | 0.5 |
Leishmania major | protein kinase, putative | 0.006 | 0.002 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.0942 | 1 | 0.5 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.0942 | 1 | 1 |
Loa Loa (eye worm) | CMGC/MAPK/JNK protein kinase | 0.0224 | 0.1877 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0122 | 0.0728 | 0.5 |
Loa Loa (eye worm) | CAMK/CAMKL/CHK1 protein kinase | 0.0163 | 0.1187 | 0.6326 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.0155 | 0.1101 | 0.5863 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.